Windlas Biotech Q3 FY25 Results
Windlas Biotech has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 195.02 Cr
- Quarter-on-Quarter (QoQ) Change: 4.29% (Previous Quarter: Rs. 187.00 Cr )
- Year-on-Year (YoY) Change: 20.22% (Same Quarter Last Year: Rs. 162.21 Cr )
Profitability Metrics
- Net Profit: Rs. 15.58 Cr
- QoQ Profit Change: -0.52% (Previous Quarter: Rs. 15.66 Cr )
- YoY Profit Change: 3.17% (Same Quarter Last Year: Rs. 15.10 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 7.45
- QoQ EPS Change: -0.53% (Previous Quarter: Rs. 7.49)
- YoY EPS Change: 2.62% (Same Quarter Last Year: Rs. 7.26)
Performance Summary
Moderate Growth
Windlas Biotech had moderate growth, with sales increasing more than profits. They're selling more but might need to manage costs better.
This analysis provides a snapshot of Windlas Biotech's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.